It was recently announced that the Trump administration was going to halt all investments in Gavi, the Vaccine Alliance.

The Trump administration is expanding its data push, reaching into domains long controlled by the states — and further into ...

Even if you don't rely on Medicaid, the cuts signed into law by President Donald Trump will affect everyone, according to ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

President Donald Trump is ratcheting up pressure on some of the world’s biggest drug companies to reduce their prices in the U.S. or risk consequences.

Government programs may soon change how they approach a growing public health challenge that affects millions of Americans each year.

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

A Democratic PAC aimed at supporting statewide Democrats in 2026 launched its campaign against their GOP opponents Thursday, ...

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...

President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to ...

Another Chicago hospital has ended gender-affirming pediatric surgery amid threats to its federal funding. But Illinois and 15 other states are fighting back in a federal lawsuit against the Trump ...